{"id":"naltrexone-plus-gabapentin","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Somnolence"},{"rate":null,"effect":"Hepatotoxicity (naltrexone)"}]},"_chembl":{"chemblId":"CHEMBL940","moleculeType":"Small molecule","molecularWeight":"171.24"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Naltrexone is an opioid antagonist that prevents opioid binding to mu, delta, and kappa receptors, reducing euphoric effects and cravings. Gabapentin enhances GABAergic inhibitory neurotransmission and modulates voltage-gated calcium channels, reducing neuropathic pain and anxiety. The combination targets both the reward pathway and pain/withdrawal symptoms associated with opioid dependence.","oneSentence":"Naltrexone blocks opioid receptors while gabapentin modulates calcium channels and GABA neurotransmission to reduce pain and cravings in opioid use disorder.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:22:34.215Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Opioid use disorder"},{"name":"Opioid withdrawal symptoms and pain management"}]},"trialDetails":[{"nctId":"NCT05827159","phase":"PHASE3","title":"Emergency Department-Initiated Medications for Alcohol Use Disorder","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-08-17","conditions":"Alcohol Use Disorder","enrollment":240},{"nctId":"NCT06488586","phase":"","title":"IV Ketamine Vs. in Esketamine for MDD TRD","status":"RECRUITING","sponsor":"Gustavo Vazquez","startDate":"2023-03-20","conditions":"Treatment Resistant Depression","enrollment":80},{"nctId":"NCT04052139","phase":"PHASE2","title":"St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Gabapentin","status":"COMPLETED","sponsor":"Boston Medical Center","startDate":"2021-01-25","conditions":"Chronic Pain, Alcohol Use, Unspecified, HIV Infections","enrollment":45},{"nctId":"NCT00183196","phase":"PHASE3","title":"Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2003-01","conditions":"Alcohol Dependence","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Naltrexone plus Gabapentin","genericName":"Naltrexone plus Gabapentin","companyName":"Medical University of South Carolina","companyId":"medical-university-of-south-carolina","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Naltrexone blocks opioid receptors while gabapentin modulates calcium channels and GABA neurotransmission to reduce pain and cravings in opioid use disorder. Used for Opioid use disorder, Opioid withdrawal symptoms and pain management.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}